COVID Vaccine From Hyderabad Gets EUL From WHO

Hyderabad, Jan 16 (Maxim News): Hyderabad-based vaccine manufacturer Biological E. Limited (BE) on Tuesday announced receiving Emergency Use Listing (EUL) from World Health Organization (WHO) for its Corbevax, the Covid-19 vaccine that is based on a protein sub-unit platform.

Managing Director, Biological E Limited, Mahima Datla said the EUL will help continue developing Covid-19 vaccines as and when it starts impacting public health. “We understand several countries come under fiscal pressure when it comes to dealing with Covid-19. We aim to reach the people in those countries with Corbevax,” she said.

Corbevax vaccine has already received a green signal from Drugs Controller General of India (DCGI) for restricted use in emergencies among adults, adolescents and young children in December’21 to April 22. It also received regulatory permission for the use as a heterologous Covid-19 booster shot for adults over 18 years.

As a part of the Covid immunization drive for 12 to 14 years children, so far Biological E Limited has supplied 100 million doses of Corbevax to the Central Government.

“While several companies which entered the field of vaccine development and manufacturing during the Covid pandemic, exited afterwards either due to paucity of funds or lack of success, we continue to remain active to develop and provide access to better and affordable vaccines globally,’’ Mahima Datla said.

BE is working on a next-generation Covid-19 vaccine that is based on the XBB1.5 variant of the SARS-CoV-2 virus, which would conform to WHO TAG-CO-VAC recommendations. The candidate vaccine has completed all required pre-clinical animal studies, which suggest that it will provide adequate protection against the currently circulating variants.

BE has recently received final approval from CDSCO to begin clinical trials of the XBB.1.5 variant vaccine in India and clinical trials will commence soon. (Maxim News)


Next Story :

  • Raja Singh Sparks Controversy Again: Advises Ayyappa Devotees’ To Visit Vavar Mosque

    Raja Singh Sparks Controversy Again: Advises Ayyappa Devotees’ To Visit Vavar Mosque

    Hyderabad, Nov 22 (Maxim News): Goshamahal BJP MLA Raja Singh, sparked controversy after advising Ayyappa Swamy devotees not to visit the Vavar mosque of Hazrath Vavarswami Darga and mosque—popularly known as Vavar mosque—when traveling to the Sabarimala Temple in Kerala.


  • Telangana: DCA Cracks Down On Fake Drug Claims For Critical Illness

    Telangana: DCA Cracks Down On Fake Drug Claims For Critical Illness

    Hyderabad, Nov 22 (Maxim News): The Drug Control Administration (DCA), Telangana State seized several drugs that were circulating in the market with misleading claims of treating Cardiovascular disorders, blood pressure, Ophthalmic diseases/disorders, fevers, and diabetes, which is in contravention of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, a DCA press release said.


  • Three Arrested For Practicing Allopathy In Telangana

    Three Arrested For Practicing Allopathy In Telangana

    Hyderabad, Nov 22 (Maxim News): The drug inspectors of Telangana State Drug Control Administration (TSDCA) conducted raids on the premises of three quacks (unqualified medical practitioners), who were practicing allopathy, at different locations in Telangana State and seized substantial stocks of medicines worth Rs. 83,000, stored illegally for sale.


  • Like Praja Palana Forms, Now Caste Survey Applications On Road

    Like Praja Palana Forms, Now Caste Survey Applications On Road

    Hyderabad, Nov 22 (Maxim News): The caste census survey applications have been found scattered again and this time near Tarnaka Metro station in the city on Friday. This is the second such incident being reported in the State.


Now you can get the latest stories from Indtoday on Telegram every day. Click the link to subscribe.  Click to follow Indtoday’s Facebook pageTwitter and Instagram. For all the latest Hyderabad News updates

Leave A Reply

Your email address will not be published.